Tecartus FDA Approval: ZUMA-2 Data for Mantle Cell Lymphoma
Review the FDA full approval of Tecartus for relapsed mantle cell lymphoma. This analysis covers ZUMA-2 Cohort 3 efficacy data, CAR-T safety, and clinical use.
Back to Articles
Articles tagged with “btk-inhibitors”